MMP2-Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti-Cancer Drugs in Treating Melanoma
Current cancer therapies for solid cancers involve surgery, radiotherapy, and chemotherapy, but challenges such as tumor heterogeneity, drug resistance, and poor drug delivery hinder effective treatment. Nano-oncology, specifically liposomes, shows promise by improving drug...





comments